Loopbaan van Jeffrey Greve
Eerdere bekende functies van Jeffrey Greve
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 | 23-08-2022 |
| Oprichter | 01-05-2018 | 23-08-2022 | |
Delinea, Inc. (United States)
 Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 | - |
| Oprichter | 01-01-2015 | - | |
| ATYR PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 23-09-2011 | - |
Opleiding van Jeffrey Greve
| University of Washington | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Delinea, Inc. (United States)
Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Jeffrey Greve
- Ervaring
